| Literature DB >> 31883789 |
Takashi Namba1, Judit Dóczi2, Anneline Pinson3, Lei Xing3, Nereo Kalebic3, Michaela Wilsch-Bräuninger3, Katherine R Long3, Samir Vaid3, Janelle Lauer3, Aliona Bogdanova3, Barbara Borgonovo3, Anna Shevchenko3, Patrick Keller3, David Drechsel3, Teymuras Kurzchalia3, Pauline Wimberger4, Christos Chinopoulos2, Wieland B Huttner5.
Abstract
The human-specific gene ARHGAP11B is preferentially expressed in neural progenitors of fetal human neocortex and increases abundance and proliferation of basal progenitors (BPs), which have a key role in neocortex expansion. ARHGAP11B has therefore been implicated in the evolutionary expansion of the human neocortex, but its mode of action has been unknown. Here, we show that ARHGAP11B is imported into mitochondria, where it interacts with the adenine nucleotide translocase (ANT) and inhibits the mitochondrial permeability transition pore (mPTP). BP expansion by ARHGAP11B requires its presence in mitochondria, and pharmacological inhibition of ANT function or mPTP opening mimic BP expansion by ARHGAP11B. Searching for the underlying metabolic basis, we find that BP expansion by ARHGAP11B requires glutaminolysis, the conversion of glutamine to glutamate for the tricarboxylic acid (TCA) cycle. Hence, an ARHGAP11B-induced, mitochondria-based effect on BP metabolism that is a hallmark of highly mitotically active cells appears to underlie its role in neocortex expansion.Entities:
Keywords: evolution; metabolism; neocortex; neural progenitor cells
Mesh:
Substances:
Year: 2019 PMID: 31883789 DOI: 10.1016/j.neuron.2019.11.027
Source DB: PubMed Journal: Neuron ISSN: 0896-6273 Impact factor: 17.173